Rituximab - Refractory vasculitis
You are here : Home > Formulary Search > Rituximab - Refractory vasculitis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
PAD Profile
ChemicalSubstance :
Rituximab
Indication :
Refractory vasculitis
Group Name :
Keywords :
Vasculitis
Brand Names Include :
MabThera
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Committee Recommendations (2)
Commissioned by NHS England. Treatment should be initiated by the specialist and is considered to be a RED drug on the traffic light system. GPs should not be requested to prescribe this treatment
01 Apr 13 -
Not Set
Funded by NHS England from 1st April 2013. Treatment should remain with the specialist (RED) hospital only drug.
Other Indications
Below are listed other indications that Rituximab is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Refractory vasculitis.
- No records returned.